Navigation Links
Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke

lio of vessel closure, endovascular and coronary products that are recognized internationally for their safety and effectiveness in treating patients with vascular disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com .

CONTACT: Media, Karin Bauer Aranaz, +1-415-859-3414, , Nicole Osmer, +1-650-454-0504, , or Financial, Tina Ventura, +1-847-772-5006, , all of Abbott karin.baueraranaz@av.abbott.com nicole.osmer@av.abbott.com tina.ventura@abbott.com

Web site: http://www.abbott.com/http://www.abbottvascular.com/ACCpresskit/

Ticker Symbol: (NYSE:ABT)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
2. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
3. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Abbotts Investigational Treatment ABT-874 Shows Positive Results in Phase II Psoriasis Study
6. Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
7. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
8. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
9. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product

Post Your Comments:
(Date:11/6/2009)...S.C., Nov. 6 The ,Hel...uth Carolina and Georgia throughout the week of No...nsured and financially-struggling patients access ...medicines for free or nearly free. With the nation... Partnership for Prescription Assistance (PPA) bus...
(Date:11/6/2009)....J., Nov. 6 Derma Scie...r of advanced wound care products, announced plans...market on Monday, November 16, 2009. The Company w...s the results at 11:00 am EST. Interested parties ...-1684 (international), with passcode 81416481 to a...
(Date:11/6/2009)...ov. 6 NuVasive, Inc. (Na... developing products for minimally disruptive surg... appointment of Michael J. Lambert as Executive Vi...e November 9, 2009. The Company also announced se..., "Michael will be an excellent complement to the...
Breaking Medicine Technology:Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 2Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Boy Scouts Uniform Earns Award 48315 1Boy Scouts Uniform Earns Award 48315 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5UNC scientists identify growth factor as possible cancer drug target 48310 1
...able Stent Technology Holds Promise as,Future-Gene...tients,with Coronary Artery Disease, ABBOTT PARK, ...ott today announced positive results from ABSORB, ...erall safety and performance,of a fully bioabsorba... of coronary artery disease. Six- month results fr...
...Patients Treated for Acute Coronary Syndromes,(ACS...W ORLEANS, March 26, 2007 /PRNewswire/ -- One-year... acute coronary syndrome,(ACS) patients in the "An... similar rates of ischemic clinical outcomes compa...ming previous findings,which showed similar ische...
Other Medicine Technology:Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 2Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 3Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 4Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 5Acuity One-Year Findings Meet All Primary Endpoints in Favor of,Angiomax (Bivalirudin) Alone Treatment Group 6
(Date:11/8/2009)... 3D Global Solutions is pleas...ram managing the proposal effort for ReSound who r...igital Hearing Aid contract. The award includes no...epartment of Defense and other federal agencies. ...ember 8, 2009 -- 3D Global Solutions is pleased to...
(Date:11/8/2009)..., "One victory does not mean the battle is won," ...7 In a vote of 240-194,...nski-Smith Amendment to prohibit abortion mandates... ,, Americans United for Life Action President ...this amendment is a victory for the pro-life Ameri...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 Th...irector, Operation Rescue Insurrecta Nex. ,, M...y have been fighting to keep child-killing by abor... Mr. Terry states: "This is a great first step to ... we have a lot of fighting ahead of us. Our rejoic...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 Ka... Insurance Plans (AHIP), released the following st... "Health plans strongly support comprehensive heal...scussion by proposing a complete overhaul of how h... proposed guaranteed coverage, elimination of pre-...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this a "...ion (AMA), the AMA President J. James Rohack, M.D....icians from all state and medical specialty societ...-making meeting, where health system reform will t...om/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over t...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
... for pie and mash, and missing visits to British p...cently confessed to being homesick following his m...mentary to be shown on Tuesday at 9 p.m., Becks ad... love eating when I come back to London. ...
...ians and Iraqis, will face prejudice in the wake o... and Glasgow. According to the medical jo...being used as an excuse to discriminate against ov...as been under way in the United Kingdom since the ...
...t of American youths online have been asked to sen... Internet. Researchers at the University ...h Center have found that one in 25 youth who use t...olescent Health, poses a new threat for young peop...
...icing Ayurveda, a native system of medicine, has b...ent by a city court for causing the death of a pre...incident took place two years ago. The doc..., Babli had approached the private medical practit...
... be seen in action spearheading a charity campaign... hair as a result of cancer treatment. T...le to grow their locks, get it cut, and donate it ... too. "I have lost multiple family member...
...ans glamorous clothes, high heels and choreographe... women's contest with the aim of reducing infant ...ompetition evaluates mothers' weights during pregn...m nearby hospitals, NGO members working in the slu...
Other Medicine News:Health News:Indian, Iraqi Medics may Face Terror Stigma Overseas 2Health News:Four Percent of American Youths are Requested to Post Sexual Snaps on Web 2Health News:Pregnant Women's Contest to Curb Infant Mortality 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: